Self Expanding Stents Sales

Self Expanding Stents Sales Market Outlook

The global self-expanding stents market is projected to reach approximately USD 9 billion by 2035, expanding at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2035. This growth can be attributed to several factors, including the rising prevalence of cardiovascular diseases and the increasing number of minimally invasive surgical procedures. The demand for advanced medical devices, particularly in the fields of cardiology and vascular interventions, is also fueling this market. Moreover, technological advancements in stent manufacturing, such as the development of drug-eluting stents and bioresorbable options, are contributing significantly to the market's expansion. Additionally, the growing geriatric population, who are more susceptible to various vascular complications, is expected to further accelerate the demand for self-expanding stents.

Growth Factor of the Market

The self-expanding stents market is primarily driven by the increasing incidence of coronary artery disease (CAD) and peripheral artery disease (PAD), which necessitates effective treatment options. The evolution of stent technology has made these devices more effective in addressing complex vascular issues, which in turn triggers a higher adoption rate among healthcare professionals. Furthermore, the increase in healthcare expenditure across various regions, alongside a rise in the number of interventional procedures performed globally, is expected to further enhance market growth. The shift towards outpatient surgeries and minimally invasive techniques has also led to an upsurge in the demand for self-expanding stents, as they provide better patient outcomes and faster recovery times. Lastly, government initiatives and investments in healthcare technology are expected to contribute significantly to the market expansion over the coming years.

Key Highlights of the Market

• The global self-expanding stents market is projected to reach USD 9 billion by 2035.
• The market is expanding at a CAGR of 7.5% from 2025 to 2035.
• Technological advancements in stent manufacturing significantly contribute to market growth.
• Increasing prevalence of cardiovascular diseases drives the demand for stents.
• Government investments in healthcare technology are expected to support market expansion.

By Product Type

Balloon-expandable Stents:

Balloon-expandable stents are widely utilized in interventional procedures where they are expanded through balloon inflation to secure the vessel lumen. These stents are primarily used in patients suffering from coronary artery disease, providing a mechanical support structure that prevents vessel re-narrowing after angioplasty. The ease of deployment and the ability to customize design and sizing according to patient-specific anatomical variations are significant advantages. As a result, they account for a substantial portion of the self-expanding stents market. Furthermore, ongoing innovations to enhance their materials, such as incorporating drug-eluting properties, continue to improve patient outcomes, fostering their growth within the market.

Drug-eluting Stents:

Drug-eluting stents are designed to release medication over time to inhibit the proliferation of vascular smooth muscle cells, thus reducing the risk of restenosis. They have emerged as a popular choice for treating coronary artery disease due to their effectiveness in preventing artery re-narrowing. The growing body of evidence supporting their efficacy, along with continuous technological advancements in drug delivery systems, contributes to their increased adoption. Moreover, various clinical studies demonstrating long-term benefits and the safety of drug-eluting stents further enhance their acceptance among healthcare providers, positioning them as a crucial segment within the self-expanding stents market.

Bare-metal Stents:

Bare-metal stents (BMS) are simple metallic stents that provide structural support to the blood vessels but do not elute medication. Although their use has diminished in favor of drug-eluting stents due to higher rates of restenosis, they remain important in specific clinical scenarios. For example, they may be preferred in patients at a high risk of thrombosis or those who cannot afford the costs associated with drug-eluting stents. The market for bare-metal stents is anticipated to experience gradual growth, propelled by their straightforward design and clinical efficacy in uncomplicated cases.

Bioresorbable Stents:

Bioresorbable stents represent the cutting-edge of stent technology, designed to dissolve over time after fulfilling their purpose of providing vascular support. This innovative approach aims to reduce long-term complications associated with permanent implants, such as late thrombosis and chronic inflammation. As their clinical applications expand, they are being integrated into treatment protocols for various vascular diseases. While they currently hold a smaller share of the market compared to traditional stents, the potential for reduced long-term complications and improved patient outcomes positions bioresorbable stents as a promising growth area in the self-expanding stents market.

Covered Stents:

Covered stents are specialized devices that are lined with a synthetic material, providing an additional layer of protection for the vessel. They are particularly beneficial in treating vascular conditions involving leaks or aneurysms, as the covering helps to minimize the risk of complications. The demand for covered stents has risen due to their efficacy in specific clinical situations, such as treating vascular malformations or preventing the migration of stents. The technological advancements and materials used in covered stent design continue to evolve, thereby enabling wider applications within the self-expanding stents market.

By Application

Coronary Artery Disease:

Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality globally, which in turn drives significant demand for self-expanding stents. The utilization of stents in percutaneous coronary interventions (PCI) has become a standard procedure, ensuring improved patient outcomes through the restoration of blood flow. As healthcare providers increasingly adopt advanced stenting techniques, the market for self-expanding stents in CAD applications is expected to witness robust growth. Additionally, ongoing research aimed at enhancing the efficacy and safety of stenting procedures continues to fuel technological advancements in this segment.

Peripheral Artery Disease:

Peripheral artery disease (PAD) is characterized by narrowed arteries that reduce blood flow to the limbs, leading to symptoms such as pain and mobility issues. The rising incidence of PAD, particularly among the aging population, necessitates effective treatment options, which significantly contribute to the self-expanding stents market. Self-expanding stents offer promising solutions for treating PAD, with their flexibility and ability to adapt to the localized arterial environment. As healthcare systems increasingly recognize the importance of addressing PAD, the demand for self-expanding stents will likely increase, driving market growth.

Urology:

The application of self-expanding stents in urology focuses primarily on treating ureteral obstructions and managing conditions such as kidney stones. Ureteral stents are crucial in ensuring the proper drainage of urine from the kidneys to the bladder, especially in patients undergoing various urological procedures. The increasing awareness of minimally invasive techniques and advancements in stent technology are propelling the growth of this segment. Additionally, the rising prevalence of kidney disorders and urological surgeries enhances the demand for self-expanding stents in urology, positioning this application as a vital component of the overall market.

Neurology:

Self-expanding stents are gaining traction in the field of neurology, particularly for treating conditions such as intracranial aneurysms and carotid artery stenosis. The application of stents in neurovascular procedures offers patients less invasive options to manage complex anomalies while promoting blood flow restoration. Technological advancements in neurostenting have resulted in devices designed specifically for the intricate anatomy of cerebral vessels, enhancing their efficacy. With the growing emphasis on minimally invasive techniques in neurosurgery, the use of self-expanding stents in neurology is expected to exhibit strong growth rates in the coming years.

Gastroenterology:

In gastroenterology, self-expanding stents are employed to manage a variety of conditions, including esophageal strictures and biliary obstructions. Stenting in this field aims to alleviate symptoms and improve quality of life for patients experiencing obstructive processes. The rising prevalence of gastrointestinal diseases and the shift towards less invasive treatment options are contributing to the growth of self-expanding stents in this application. Moreover, advancements in stent design and materials are facilitating better patient outcomes, thereby increasing their adoption in gastroenterological procedures.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for self-expanding stents, accounting for a significant share of market sales. The comprehensive healthcare services provided in hospitals, combined with the availability of advanced medical facilities and skilled healthcare professionals, make them ideal environments for stenting procedures. Hospitals are equipped with the necessary resources to conduct complex interventions, thus fostering the adoption of self-expanding stents. The increasing number of hospital admissions related to cardiovascular and vascular diseases further supports the growth of this distribution channel, as the demand for effective treatment options continues to rise.

Specialty Clinics:

Specialty clinics, particularly those focused on cardiology, urology, and gastroenterology, are gaining traction as important distribution channels for self-expanding stents. With a growing emphasis on patient-centered care and the increasing preference for outpatient surgical procedures, specialty clinics are well-positioned to cater to the needs of patients requiring stenting interventions. The availability of specialized healthcare professionals and advanced treatment options enhances the popularity of these clinics among patients. Furthermore, the rising trend of minimally invasive techniques is likely to continue driving the demand for self-expanding stents within specialty clinics.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as crucial distribution channels for self-expanding stents, particularly due to their focus on outpatient procedures. These centers provide a cost-effective alternative to traditional hospital settings while ensuring high-quality care. The shift towards outpatient interventions, such as stenting, has enabled ASCs to capitalize on the growing demand for minimally invasive procedures. Moreover, as patients increasingly seek convenient and efficient healthcare options, the market for self-expanding stents distributed through ASCs is expected to expand proportionally.

Online Stores:

Online stores are gradually gaining importance as a distribution channel for self-expanding stents, particularly in regions where telehealth and e-commerce are on the rise. The convenience of online purchasing, coupled with the ability to compare various products and prices, enhances accessibility for healthcare professionals and patients alike. Although the online segment is still developing, its potential cannot be overlooked, especially as digital health solutions become increasingly popular. The shift towards remote healthcare solutions is expected to drive growth in this distribution channel and positively impact the overall self-expanding stents market.

Retail Pharmacies:

Retail pharmacies serve as supplementary distribution channels for self-expanding stents, particularly in outpatient settings. Although the majority of stenting procedures are conducted in hospitals and specialty clinics, retail pharmacies play a crucial role in providing necessary support and follow-up care for patients. They offer patients access to related medical supplies and medication that may be required post-procedure. As retail pharmacies continue to expand their services to include more healthcare products and support, their role in the self-expanding stents market is expected to grow, albeit at a slower pace compared to hospitals and specialty clinics.

By Material Type

Nitinol:

Nitinol is a nickel-titanium alloy widely used in the production of self-expanding stents due to its unique properties, including excellent flexibility and shape memory characteristics. These properties allow nitinol stents to conform to the vessel's anatomy, providing optimal support while minimizing the risk of adverse reactions. Nitinol stents are particularly valuable in applications requiring complex placements, such as in peripheral artery and coronary artery interventions. The material's biocompatibility and corrosion resistance also play a vital role in enhancing patient outcomes, driving the demand for nitinol-based self-expanding stents in the market.

Stainless Steel:

Stainless steel has been a conventional material used in the manufacturing of self-expanding stents, owing to its strength and durability. Although the market share of stainless steel stents has been declining with the rise of advanced materials like nitinol, they remain relevant in specific clinical scenarios. Stainless steel stents are often employed in simpler cases where the risks of complications are lower. Moreover, their cost-effectiveness makes them an attractive option for healthcare providers, keeping them relevant in the self-expanding stents market.

Cobalt-Chromium:

Cobalt-chromium alloys are increasingly becoming popular in the development of self-expanding stents due to their inherent mechanical strength and radiopacity. These properties allow for better visualization during deployment and monitoring, which is crucial in vascular interventions. Cobalt-chromium stents have demonstrated favorable clinical outcomes in terms of reducing rates of thrombosis and restenosis. The growing adoption of cobalt-chromium stents in various applications, particularly in coronary interventions, is expected to boost their market share in the self-expanding stents industry.

Platinum-Chromium:

Platinum-chromium is an emerging material in the self-expanding stents market, known for its radiopacity and favorable mechanical properties. This alloy provides a balance between flexibility and strength, making it suitable for complex vascular anatomies. The enhanced visibility during imaging procedures has made platinum-chromium stents a preferred option among healthcare professionals for certain applications. As advancements in stent technology continue to evolve, the adoption of platinum-chromium stents is anticipated to increase, contributing to their growth in the overall market.

Polymer:

Polymer-based stents are gaining attention due to their ability to incorporate drug-eluting properties and their versatility in design. The use of biocompatible polymers in self-expanding stent construction allows for the controlled release of medications that help prevent restenosis. The customization of polymer stents for various applications, including coronary and peripheral interventions, enhances their appeal in the self-expanding stents market. As manufacturers continue to innovate in polymer technology, it is expected that the demand for polymer-based stents will grow, further diversifying the market.

By Region

The North American region holds a prominent share of the self-expanding stents market, driven primarily by the high prevalence of cardiovascular diseases and advanced healthcare infrastructure. The United States, in particular, stands out as a leader in the adoption of innovative medical devices, including self-expanding stents. The growing number of minimally invasive procedures and a strong emphasis on research and development contribute significantly to market growth in North America. Notably, the region is projected to witness a CAGR of around 7.4% during the forecast period, reflecting its status as a key market player.

Europe is another significant region for the self-expanding stents market, encompassing advanced healthcare systems that prioritize patient safety and treatment efficacy. The demand for self-expanding stents in Europe is fueled by an aging population and an increasing prevalence of chronic diseases, particularly cardiovascular and vascular disorders. The region is expected to maintain steady growth, with an anticipated CAGR of around 6.8% during the forecast period. Meanwhile, the Asia Pacific region is projected to experience the highest growth rate, primarily driven by rapid urbanization, improving healthcare access, and rising healthcare expenditure. The increasing number of interventional procedures performed in countries like China and India will further bolster the self-expanding stents market in this region.

Opportunities

The self-expanding stents market is poised to capitalize on several emerging opportunities, especially as healthcare systems worldwide continue to prioritize minimally invasive procedures. With the ongoing advancements in stent technology, including drug-eluting and bioresorbable stents, there is significant potential for market growth. Healthcare providers are increasingly recognizing the benefits of these advanced stents in managing various vascular conditions. This shift towards more sophisticated stenting solutions opens avenues for manufacturers to innovate and develop new products that cater to evolving clinical needs. Furthermore, the expansion of telemedicine and digital health solutions creates an environment where remote patient monitoring and follow-up care can enhance the overall patient experience, thereby driving the demand for self-expanding stents.

In addition to technological advancements, the growing prevalence of chronic diseases such as diabetes and hypertension, which are known risk factors for vascular complications, presents ample opportunities for the self-expanding stents market. As awareness regarding preventive care increases, healthcare systems are likely to invest more in interventions that address these underlying conditions. Additionally, global healthcare initiatives aimed at improving patient access to quality care are expected to create favorable conditions for market growth. Collaborations and partnerships between key stakeholders, including healthcare providers, device manufacturers, and regulatory bodies, can further facilitate the development and distribution of self-expanding stents, ensuring that patients receive timely and effective treatment.

Threats

Despite the significant growth potential in the self-expanding stents market, several threats could pose challenges to market expansion. One of the primary threats is the increasing competition from alternative treatment options, such as balloon angioplasty or other vascular interventions that do not involve stenting. As healthcare providers continue to explore various treatment modalities, the market share of self-expanding stents may be inadvertently affected, particularly in cases where simpler interventions yield satisfactory results. Additionally, the emergence of advanced technologies, such as bioengineered vessels or regenerative medicine approaches, could potentially disrupt the established stent market by providing innovative solutions that address vascular health issues.

Another significant threat comes from stringent regulatory requirements associated with medical devices, particularly in regions with rigorous approval processes. The time and costs involved in obtaining regulatory approvals can act as barriers for new entrants and even established players in the market. Furthermore, any potential safety concerns related to the use of stents, such as late thrombosis or allergic reactions to materials, could lead to recalls or increased scrutiny from regulatory agencies, negatively impacting manufacturers' reputations and sales. To mitigate these threats, stakeholders must focus on continuous innovation, robust clinical data, and effective risk management strategies to maintain their competitive advantage in the self-expanding stents market.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic PLC
• Abbott Laboratories
• Cardinal Health, Inc.
• Johnson & Johnson
• Terumo Corporation
• Cook Medical, Inc.
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• B.Braun Melsungen AG
• iVascular, S.L.
• Asahi Intecc Co., Ltd.
• STENTYS S.A.
• Philips Healthcare
• W. L. Gore & Associates, Inc.

The competitive landscape of the self-expanding stents market is characterized by the presence of several key players engaged in continuous innovation and strategic partnerships to enhance product offerings and expand market reach. Companies such as Boston Scientific Corporation and Medtronic PLC are prominent players with extensive portfolios that cover a wide range of stenting solutions. They invest heavily in research and development to introduce advanced stent designs and materials that address specific clinical needs. Additionally, these companies often engage in strategic collaborations with healthcare providers to improve patient education and adoption of their products, thereby strengthening their market position.

Abbott Laboratories and Johnson & Johnson are also major competitors in the self-expanding stents market, recognized for their commitment to delivering high-quality medical devices. Both companies have established robust distribution networks that enable them to reach healthcare facilities and specialty clinics effectively. Furthermore, their focus on developing drug-eluting stents and other innovative technologies ensures that they remain at the forefront of the market. The competitive rivalry among these major players is centered around enhancing the safety and efficacy of their products while addressing regulatory requirements and patient safety concerns.

Emerging companies such as iVascular and STENTYS are carving out their niche in the self-expanding stents market by introducing novel technologies and approaches to vascular interventions. Their commitment to innovation and customer-centric product designs has garnered attention from healthcare professionals and patients alike. As these companies continue to grow, they are likely to challenge established players by offering unique solutions tailored to specific patient demographics. The competitive landscape will continue to evolve, driven by a focus on product differentiation, strategic partnerships, and a shared objective of improving patient outcomes in vascular health.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 STENTYS S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic PLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 iVascular, S.L.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Johnson & Johnson
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cook Medical, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Philips Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 B.Braun Melsungen AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Biotronik SE & Co. KG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Cardinal Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asahi Intecc Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 W. L. Gore & Associates, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 MicroPort Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Self Expanding Stents Sales Market, By Application
    • 6.1.1 Coronary Artery Disease
    • 6.1.2 Peripheral Artery Disease
    • 6.1.3 Urology
    • 6.1.4 Neurology
    • 6.1.5 Gastroenterology
  • 6.2 Self Expanding Stents Sales Market, By Product Type
    • 6.2.1 Balloon-expandable Stents
    • 6.2.2 Drug-eluting Stents
    • 6.2.3 Bare-metal Stents
    • 6.2.4 Bioresorbable Stents
    • 6.2.5 Covered Stents
  • 6.3 Self Expanding Stents Sales Market, By Material Type
    • 6.3.1 Nitinol
    • 6.3.2 Stainless Steel
    • 6.3.3 Cobalt-Chromium
    • 6.3.4 Platinum-Chromium
    • 6.3.5 Polymer
  • 6.4 Self Expanding Stents Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Stores
    • 6.4.5 Retail Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Self Expanding Stents Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Self Expanding Stents Sales market is categorized based on

By Product Type

• Balloon-expandable Stents
• Drug-eluting Stents
• Bare-metal Stents
• Bioresorbable Stents
• Covered Stents

By Application

• Coronary Artery Disease
• Peripheral Artery Disease
• Urology
• Neurology
• Gastroenterology

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Stores
• Retail Pharmacies

By Material Type

• Nitinol
• Stainless Steel
• Cobalt-Chromium
• Platinum-Chromium
• Polymer

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Medtronic PLC
• Abbott Laboratories
• Cardinal Health, Inc.
• Johnson & Johnson
• Terumo Corporation
• Cook Medical, Inc.
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• B.Braun Melsungen AG
• iVascular, S.L.
• Asahi Intecc Co., Ltd.
• STENTYS S.A.
• Philips Healthcare
• W. L. Gore & Associates, Inc.